{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:58Z","timestamp":1793126038459,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["DDMUR_47_2025_EVOLVE"],"award-info":[{"award-number":["DDMUR_47_2025_EVOLVE"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022NBKCWP"],"award-info":[{"award-number":["2022NBKCWP"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101078646"],"award-info":[{"award-number":["101078646"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP J97G22000170005"],"award-info":[{"award-number":["CUP J97G22000170005"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["ECS00000041"],"award-info":[{"award-number":["ECS00000041"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107650","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:58:25Z","timestamp":1788188305000},"page":"107650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipid nanoparticles for ursodeoxycholic acid delivery: A strategy for topical applications"],"prefix":"10.1016","volume":"227","author":[{"given":"Giada","family":"Mondanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gargaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Schoubben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antimo","family":"Gioiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107650_bib0001","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s12035-014-9043-8","article-title":"Ursodeoxycholic acid ameliorates apoptotic cascade in the rotenone model of Parkinson\u2019s disease: modulation of mitochondrial perturbations","volume":"53","author":"Abdelkader","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejps.2026.107650_bib0002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/pharmaceutics15020656","article-title":"Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications","volume":"15","author":"Akombaetwa","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107650_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2018.09.001","article-title":"Research techniques made simple: transepidermal water loss measurement as a research tool","volume":"138","author":"Alexander","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2026.107650_bib0004","article-title":"Effect of the aggregation state of bile salts on their transdermal absorption enhancing properties","volume":"54","author":"Alvarez-Figueroa","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2026.107650_bib0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2019.03.056","article-title":"QbD guided early pharmaceutical development study: production of lipid nanoparticles by high pressure homogenization for skin cancer treatment","volume":"563","author":"Amasya","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107650_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.trac.2012.02.007","article-title":"Quantitative 1H NMR spectroscopy","volume":"35","author":"Bharti","year":"2012","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ejps.2026.107650_bib0007","first-page":"476","article-title":"Assessing the clinical efficacy of Ursodeoxycholic acid (UDCA) as a local drug delivery agent in the treatment of intra-bony defects: a clinico-radiographic study","volume":"8","author":"Bolla","year":"2023","journal-title":"Int. J. Res. Trends Innov."},{"key":"10.1016\/j.ejps.2026.107650_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110823","article-title":"Development of microemulsion based topical ivermectin formulations: pre-formulation and formulation studies","volume":"189","author":"Das","year":"2020","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2026.107650_bib0009","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jconrel.2020.02.033","article-title":"Nasal administration of nanoencapsulated geraniol\/ursodeoxycholic acid conjugate: towards a new approach for the management of Parkinson\u2019s disease","volume":"321","author":"de Oliveira Junior","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2026.107650_bib0010","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2026.107650_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226748","article-title":"Potential effects of ursodeoxycholic acid on accelerating cutaneous wound healing","volume":"14","author":"El-Hamoly","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2026.107650_bib0012","series-title":"ICH Q2(R2) Guideline on Validation of Analytical Procedures \u2013 Step 5 (EMA\/CHMP\/ICH\/82072\/2006)","year":"2024"},{"key":"10.1016\/j.ejps.2026.107650_bib0013","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/IJN.S16815","article-title":"Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies","volume":"6","author":"Farboud","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2026.107650_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.scp.2017.07.002","article-title":"Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery","volume":"6","author":"Ganesan","year":"2017","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.ejps.2026.107650_bib0015","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.3748\/wjg.v19.i31.5029","article-title":"Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed","volume":"19","author":"Guarino","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2026.107650_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/asj.70038","article-title":"Ursodeoxycholic acid alleviates palmitic acid-induced apoptosis in bovine mammary epithelial cells","volume":"96","author":"Habib","year":"2025","journal-title":"Anim. Sci. J."},{"key":"10.1016\/j.ejps.2026.107650_bib0017","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13346-024-01642-6","article-title":"Topical gel formulations as potential dermal delivery carriers for green-synthesized zinc oxide nanoparticles","volume":"15","author":"Hamed","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2026.107650_bib0018","first-page":"378","article-title":"A comparative histological study on the skin occlusion performance of a cream made of solid lipid nanoparticles and vaseline","volume":"10","author":"Hamishehkar","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107650_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124377","article-title":"Improvement of lidocaine skin permeation by using passive and active enhancer methods","volume":"660","author":"Hasanpour","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107650_bib0020","first-page":"35","article-title":"Enhancement of the solubility and bioavailability of Ursodeoxycholic acid through a self nano emulsifying drug delivery system","volume":"9","author":"Indhumathi","year":"2024","journal-title":"Int. J. Res. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107650_bib0021","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2230.2007.02401.x","article-title":"Psoriasis treated with ursodeoxycholic acid: three case reports","volume":"32","author":"Itoh","year":"2007","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejps.2026.107650_bib0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3126\/jncs.v44i1.62683","article-title":"Design of hydrogel for the drug delivery of less permeable ursolic acid isolated from rhododendron arboreum flower in animal skin membrane","volume":"44","author":"Joshi","year":"2024","journal-title":"J. Nepal Chem. Soc."},{"key":"10.1016\/j.ejps.2026.107650_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2014.08.008","article-title":"Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants","volume":"474","author":"Keck","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107650_bib0024","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/THC-191845","article-title":"Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants","volume":"28","author":"Kecman","year":"2020","journal-title":"Technol. Health Care"},{"key":"10.1016\/j.ejps.2026.107650_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122560","article-title":"Ursodeoxycholic acid alleviates atopic dermatitis-associated inflammatory responses in HaCaT and RBL-2H3 cells and DNCB\/DFE-treated mice","volume":"344","author":"Kim","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2026.107650_bib0026","article-title":"Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2026.107650_bib0027","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.3390\/cimb46060364","article-title":"Anti-inflammatory response of new postbiotics in TNF-\u03b1\/IFN-\u03b3-induced atopic dermatitis-like HaCaT keratinocytes","volume":"46","author":"Kim","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ejps.2026.107650_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13455","article-title":"Evaluating the efficacy of ursodeoxycholic acid plus methotrexate vs methotrexate alone in the treatment of moderate to severe plaque-type psoriasis: a randomized clinical trial","volume":"33","author":"Lajevardi","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ejps.2026.107650_bib0029","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0006-2952(02)01391-6","article-title":"Antioxidant properties of ursodeoxycholic acid","volume":"64","author":"Lapenna","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107650_bib0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid \u201cmechanisms of action and clinical use in hepatobiliary disorders.\u201d","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejps.2026.107650_bib0031","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2026.107650_bib0032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.22270\/jddt.v11i1-s.4533","article-title":"Excipients, drug release mechanism and physicochemical characterization methods of solid lipid nanoparticles","volume":"11","author":"Matta","year":"2021","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.ejps.2026.107650_bib0033","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3390\/molecules30051181","article-title":"The pharmaceutical and pharmacological potential applications of bilosomes as nanocarriers for drug delivery","volume":"30","author":"Mitrovi\u0107","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2026.107650_bib0034","doi-asserted-by":"crossref","first-page":"47371","DOI":"10.1074\/jbc.M107098200","article-title":"Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid","volume":"276","author":"Miura","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2026.107650_bib0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/antiox10020267","article-title":"Ursodeoxycholic acid may inhibit environmental aging-associated hyperpigmentation","volume":"10","author":"Moon","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejps.2026.107650_bib0036","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/cbf.3732","article-title":"Bile acid-based advanced drug delivery systems, bilosomes and micelles as novel carriers for therapeutics","volume":"40","author":"Nemati","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejps.2026.107650_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2024.100814","article-title":"Advancing lipid nanoparticles: a pioneering technology in cosmetic and dermatological treatments","volume":"64","author":"Pareek","year":"2025","journal-title":"Colloid Interface Sci. Commun."},{"key":"10.1016\/j.ejps.2026.107650_bib0038","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2026.107650_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01283","article-title":"Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles","volume":"9","author":"Pavlovi\u0107","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107650_bib0040","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2026.107650_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415980","article-title":"Nanoparticles for topical application in the treatment of skin dysfunctions-an overview of dermo-cosmetic and dermatological products","volume":"23","author":"Raszewska-Famielec","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107650_bib0042","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0731-7085(97)00184-2","article-title":"Development in release testing of topical dosage forms: use of the Enhancer CellTM with automated sampling","volume":"17","author":"Rege","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2026.107650_bib0043","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2026.107650_bib0044","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.cdd.4400560","article-title":"Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation","volume":"6","author":"Rodrigues","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejps.2026.107650_bib0045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1517\/13543784.10.7.1243","article-title":"The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent","volume":"10","author":"Rodrigues","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejps.2026.107650_bib0046","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/cosmetics12010022","article-title":"Lipid nanoparticles and skin: discoveries and advances","volume":"12","author":"Santonocito","year":"2025","journal-title":"Cosmetics"},{"key":"10.1016\/j.ejps.2026.107650_bib0047","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1126\/science.abj3013","article-title":"High-speed fluorescence image-enabled cell sorting","volume":"375","author":"Schraivogel","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejps.2026.107650_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.10.027","article-title":"Bile acids improve psoriasiform dermatitis through inhibition of IL-17A expression and CCL20-CCR6-mediated trafficking of T cells","volume":"142","author":"Shi","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2026.107650_bib0049","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.copbio.2013.08.004","article-title":"Universal quantitative NMR analysis of complex natural samples","volume":"25","author":"Simmler","year":"2014","journal-title":"Curr. Opin. Biotechnol. Anal. Biotechnol."},{"key":"10.1016\/j.ejps.2026.107650_bib0050","unstructured":"Song, Y.H., Ko, H.J., 2019. Composition for prevention or treatment of inflammatory skin diseases or severe pruritus comprising the aqueous solubilized ursodeoxycholic acid. US20190192539A1."},{"key":"10.1016\/j.ejps.2026.107650_bib0051","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17425247.2020.1727883","article-title":"SLN and NLC for topical, dermal, and transdermal drug delivery","volume":"17","author":"Souto","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107650_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e08938","article-title":"Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery","volume":"8","author":"Souto","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejps.2026.107650_bib0053","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2004.02.015","article-title":"Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations","volume":"58","author":"Souto","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107650_bib0054","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.colsurfa.2019.04.082","article-title":"Nanostructured lipid carriers incorporated in alginate hydrogel: enhanced stability and modified behavior in gastrointestinal tract","volume":"574","author":"Sun","year":"2019","journal-title":"Colloids Surf. A"},{"key":"10.1016\/j.ejps.2026.107650_bib0055","unstructured":"Vijaybhai, R.P., Patel, M.P., Chhabri, M.T., 2023. A supersaturable self-nanoemulsifying drug delivery system (SNEDDS) of ursodeoxycholic acid. IN202321017462."},{"key":"10.1016\/j.ejps.2026.107650_bib0056","article-title":"Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro and in vivo evaluation","volume":"72","author":"Wairkar","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2026.107650_bib0057","unstructured":"Widauer, J.O., 1996. Use of bile acids for the preparation of a medicament for the treatment of skin disorders. EP0720854A1."},{"key":"10.1016\/j.ejps.2026.107650_bib0058","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s13346-021-01021-5","article-title":"Are lipid nanoparticles really superior? A holistic proof of concept study","volume":"12","author":"Wiemann","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2026.107650_bib0059","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/all.12019","article-title":"Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor","volume":"67","author":"Willart","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.ejps.2026.107650_bib0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mrc.4533","article-title":"Complex mixtures by NMR and complex NMR for mixtures: experimental and publication challenges","volume":"55","author":"Wist","year":"2017","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ejps.2026.107650_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.ejps.2026.107650_bib0062","unstructured":"Yu\u00e1n, H., Hu\u00e1ng, X., L\u01d0, X., 2012. Ursodeoxycholic acid nano suspension and preparation method thereof. CN101606906B."},{"key":"10.1016\/j.ejps.2026.107650_bib0063","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 drug release and release mechanism","volume":"45","author":"zur M\u00fchlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:51:33Z","timestamp":1793123493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S0928098726002241"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107650","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticles for ursodeoxycholic acid delivery: A strategy for topical applications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107650"}}